Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent

The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dITmAgW
via IFTTT